{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:47:31Z","timestamp":1792795651601,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272722"],"award-info":[{"award-number":["82272722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972838"],"award-info":[{"award-number":["81972838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200019"],"award-info":[{"award-number":["82200019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102805"],"award-info":[{"award-number":["82102805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2023ZZTS0843"],"award-info":[{"award-number":["2023ZZTS0843"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114788","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:32:20Z","timestamp":1747211540000},"page":"114788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["SSTR2 exhibits a positive correlation with PD-L1 and predicts poor prognosis in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"158","author":[{"given":"Yao","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1732","key":"10.1016\/j.intimp.2025.114788_bb0005","first-page":"20160270","article-title":"Epstein-Barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.114788_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.intimp.2025.114788_bb0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114788_bb0020","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1111\/cas.15433","article-title":"Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T-cell activity and promotes immune escape","volume":"113","author":"Yang","year":"2022","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114788_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17425247.2021.1825376","article-title":"Platinum-based chemotherapy in combination with PD-1\/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action","volume":"18","author":"Xue","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"19","key":"10.1016\/j.intimp.2025.114788_bb0030","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","article-title":"Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1","volume":"81","author":"Ge","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.114788_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104223","article-title":"Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas","volume":"193","author":"Fan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114788_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0042-116025","article-title":"Somatostatin receptor type 2 (SSTR2) internalization and intracellular trafficking in pituitary GH-secreting adenomas: role of scaffold proteins and implications for pharmacological resistance","volume":"49","author":"Treppiedi","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.114788_bb0045","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1210\/jc.2003-030303","article-title":"Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion","volume":"88","author":"Ren","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2025.114788_bb0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-23-2533","article-title":"Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma","volume":"30","author":"Kurz","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.114788_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"19","key":"10.1016\/j.intimp.2025.114788_bb0060","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.3390\/cancers13194944","article-title":"SSTR2 in nasopharyngeal carcinoma: relationship with latent EBV infection and potential as a therapeutic target","volume":"13","author":"Emanuel","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2025.114788_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41467-020-20308-8","article-title":"Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy","volume":"12","author":"Lechner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114788_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.humpath.2021.08.004","article-title":"Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"117","author":"Viswanathan","year":"2021","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114788_bb0075","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JVI.77.7.4139-4148.2003","article-title":"A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus","volume":"77","author":"Chen","year":"2003","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.intimp.2025.114788_bb0080","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.intimp.2025.114788_bb0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/microorganisms9030603","article-title":"Epstein-Barr virus LMP1 induces soluble PD-L1 in nasopharyngeal carcinoma","volume":"9","author":"Kase","year":"2021","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.intimp.2025.114788_bb0090","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PAS.0000000000002011","article-title":"Challenges in the diagnosis of Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma: extremely wide morphologic Spectrum and Immunophenotype","volume":"47","author":"Li","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.intimp.2025.114788_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/cancers14010162","article-title":"Correlation of somatostatin receptor 1\u20135 expression, [68Ga]Ga- DOTANOC, [18F]F- FDG PET\/CT and clinical outcome in a prospective cohort of pancreatic neuroendocrine neoplasms","volume":"14","author":"Majala","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2025.114788_bb0100","first-page":"580","article-title":"Validation of immunohistochemistry for somatostatin receptor subtype 2A in human somatotropinomas: comparison between quantitative real time RT- PCR and immunohistochemistry","volume":"35","author":"Wildemberg","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.intimp.2025.114788_bb0105","article-title":"SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma","volume":"27","author":"Xu","year":"2023","journal-title":"J Clin Pathol. Published online September"},{"key":"10.1016\/j.intimp.2025.114788_bb0110","series-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study published correction appears in Lancet","first-page":"272","volume":"395(10220)","author":"Burtness","year":"2020"},{"issue":"6","key":"10.1016\/j.intimp.2025.114788_bb0115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114788_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41698-024-00601-1","article-title":"Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma","volume":"8","author":"Liu","year":"2024","journal-title":"NPJ Precis Oncol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.114788_bb0125","article-title":"Combinations of radiotherapy with immunotherapy in nasopharyngeal carcinoma","volume":"125","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114788_bb0130","doi-asserted-by":"crossref","first-page":"1410250","DOI":"10.3389\/fimmu.2024.1410250","article-title":"Case report: immunotherapy-based combination therapy achieving complete remission and prolonged survival in nasopharyngeal carcinoma with extensive bone marrow metastasis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114788_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40425-019-0636-7","article-title":"Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials","volume":"7","author":"Lv","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2025.114788_bb0140","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/pharmaceutics14071394","article-title":"Comprehensive assessment of somatostatin receptors in various neoplasms: a systematic review","volume":"14","author":"Priyadarshini","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.114788_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-016-0461-y","article-title":"SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males","volume":"11","author":"Shen","year":"2016","journal-title":"Diagn. Pathol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114788_bb0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2967\/jnumed.121.262928","article-title":"Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET\/CT using coefficient of variation in patients with neuroendocrine tumors","volume":"63","author":"Fonti","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114788_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12022-020-09623-4","article-title":"Histopathological and Immunophenotypic changes of pancreatic neuroendocrine tumors after neoadjuvant peptide receptor radionuclide therapy (PRRT)","volume":"31","author":"Schiavo Lena","year":"2020","journal-title":"Endocr. Pathol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925007787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925007787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:48:51Z","timestamp":1762552131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925007787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"alternative-id":["S1567576925007787"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114788","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SSTR2 exhibits a positive correlation with PD-L1 and predicts poor prognosis in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114788"}}